Researchers at Foothills Hospital in Calgary, Canada have done research that claims that TIAs (mini strokes) could cause long-term disability, and that clot busting drugs like Actilyse could be used to treat them.
The Medical Research Council (MRC) has launched a new £5m call for capital investment to support between two and five human tissue banks with linked data resources. Awards will be made to teams of academics working in close partnership with medical research charities.
We want the research we fund to make a difference in people’s lives. That’s why we think it’s important for researchers to involve stroke survivors in their projects. Stroke survivors’ experiences can improve the quality of research, and help researchers to be more confident that their work will benefit people affected by stroke.
Why do we fund research?
Published in the European Journal of Emergency Medicine (EJEM), a new review of the existing research sheds light on how frequently patients with a stroke mimic condition present for emergency care as having a stroke.
We fund research to improve how we can stop, treat and support people to rebuild their lives after stroke. Learn more about the research we fund.
Postgraduate fellowship: What is the impact of damaged thinking ability caused by a spontaneous bleed in the brain?
‘Supported self-management’ is the help and support offered to stroke survivors and their families after they have left hospital. This research will look at what does and doesn’t work to help stroke survivors and their families to self-manage.
There is evidence that during the coronavirus pandemic fewer people have been recorded to have transient ischaemic attack (TIA) or stroke. That’s why the Stroke Association is urging people to continue to act fast and call 999 if they experience signs of stroke.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after brain haemorrhage.